Health AI Central
Share:
Peer-Reviewed Publication
Bone Marrow Transplant2023;58(12):1406-1409.December 1, 2023Clinical Trial, Phase II

Randomized phase 2 study of digital life coaching during transplantation for myeloma.

Rahul Banerjee1, Chiung-Yu Huang2, Chloe Ryan3, Albert Lee4, Kelly J Brassil5, Jasmine Moore5, Shagun Arora6, Alfred Chung6, Sandy W Wong6, Jeffrey Wolf6, Thomas Martin6, Anand Dhruva6, Nina Shah6
1Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA. rahul.banerjee.md@gmail.com.
2Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.
3Be the Match, National Marrow Donor Program, Minneapolis, MN, USA.
4School of Medicine, University of California San Diego, San Diego, CA, USA.
5Pack Health, A Quest Diagnostics Company, Birmingham, AL, USA.
6Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.